Literature DB >> 28576981

STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection.

Matthew T Stier1, Kasia Goleniewska2, Jacqueline Y Cephus2, Dawn C Newcomb1,2, Taylor P Sherrill2, Kelli L Boyd1, Melissa H Bloodworth1, Martin L Moore3, Kong Chen4, Jay K Kolls4, R Stokes Peebles5,2.   

Abstract

The appropriate orchestration of different arms of the immune response is critical during viral infection to promote efficient viral clearance while limiting immunopathology. However, the signals and mechanisms that guide this coordination are not fully understood. IFNs are produced at high levels during viral infection and have convergent signaling through STAT1. We hypothesized that STAT1 signaling during viral infection regulates the balance of innate lymphoid cells (ILC), a diverse class of lymphocytes that are poised to respond to environmental insults including viral infections with the potential for both antiviral or immunopathologic functions. During infection with respiratory syncytial virus (RSV), STAT1-deficient mice had reduced numbers of antiviral IFN-γ+ ILC1 and increased numbers of immunopathologic IL-5+ and IL-13+ ILC2 and IL-17A+ ILC3 compared with RSV-infected wild-type mice. Using bone marrow chimeric mice, we found that both ILC-intrinsic and ILC-extrinsic factors were responsible for this ILC dysregulation during viral infection in STAT1-deficient mice. Regarding ILC-extrinsic mechanisms, we found that STAT1-deficient mice had significantly increased expression of IL-33 and IL-23, cytokines that promote ILC2 and ILC3, respectively, compared with wild-type mice during RSV infection. Moreover, disruption of IL-33 or IL-23 signaling attenuated cytokine-producing ILC2 and ILC3 responses in STAT1-deficient mice during RSV infection. Collectively, these data demonstrate that STAT1 is a key orchestrator of cytokine-producing ILC responses during viral infection via ILC-extrinsic regulation of IL-33 and IL-23.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28576981      PMCID: PMC5505788          DOI: 10.4049/jimmunol.1601984

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

1.  IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones.

Authors:  P Parronchi; M De Carli; R Manetti; C Simonelli; S Sampognaro; M P Piccinni; D Macchia; E Maggi; G Del Prete; S Romagnani
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

2.  Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses.

Authors:  Kazuyo Moro; Hiroki Kabata; Masanobu Tanabe; Satoshi Koga; Natsuki Takeno; Miho Mochizuki; Koichi Fukunaga; Koichiro Asano; Tomoko Betsuyaku; Shigeo Koyasu
Journal:  Nat Immunol       Date:  2015-11-23       Impact factor: 25.606

3.  Respiratory syncytial virus infection in the absence of STAT 1 results in airway dysfunction, airway mucus, and augmented IL-17 levels.

Authors:  Koichi Hashimoto; Joan E Durbin; Weisong Zhou; Robert D Collins; Samuel B Ho; Jay K Kolls; Patricia J Dubin; James R Sheller; Kasia Goleniewska; Jamye F O'Neal; Sandra J Olson; Daphne Mitchell; Barney S Graham; R Stokes Peebles
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

4.  Role for innate IFNs in determining respiratory syncytial virus immunopathology.

Authors:  Teresa R Johnson; Sara E Mertz; Negin Gitiban; Sue Hammond; Robin Legallo; Russell K Durbin; Joan E Durbin
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

5.  Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.

Authors:  Martin L Moore; Michael H Chi; Kasia Goleniewska; Joan E Durbin; R Stokes Peebles
Journal:  Viral Immunol       Date:  2008-09       Impact factor: 2.257

6.  Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells.

Authors:  Jun Young Hong; J Kelley Bentley; Yutein Chung; Jing Lei; Jessica M Steenrod; Qiang Chen; Uma S Sajjan; Marc B Hershenson
Journal:  J Allergy Clin Immunol       Date:  2014-06-06       Impact factor: 10.793

7.  Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

Authors:  Julie Toubiana; Satoshi Okada; Julia Hiller; Matias Oleastro; Macarena Lagos Gomez; Juan Carlos Aldave Becerra; Marie Ouachée-Chardin; Fanny Fouyssac; Katta Mohan Girisha; Amos Etzioni; Joris Van Montfrans; Yildiz Camcioglu; Leigh Ann Kerns; Bernd Belohradsky; Stéphane Blanche; Aziz Bousfiha; Carlos Rodriguez-Gallego; Isabelle Meyts; Kai Kisand; Janine Reichenbach; Ellen D Renner; Sergio Rosenzweig; Bodo Grimbacher; Frank L van de Veerdonk; Claudia Traidl-Hoffmann; Capucine Picard; Laszlo Marodi; Tomohiro Morio; Masao Kobayashi; Desa Lilic; Joshua D Milner; Steven Holland; Jean-Laurent Casanova; Anne Puel
Journal:  Blood       Date:  2016-04-25       Impact factor: 22.113

8.  CD4(+) T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability.

Authors:  K J Maloy; C Burkhart; T M Junt; B Odermatt; A Oxenius; L Piali; R M Zinkernagel; H Hengartner
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

9.  The prostaglandin D₂ receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung.

Authors:  E D Tait Wojno; L A Monticelli; S V Tran; T Alenghat; L C Osborne; J J Thome; C Willis; A Budelsky; D L Farber; D Artis
Journal:  Mucosal Immunol       Date:  2015-04-08       Impact factor: 7.313

10.  Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation.

Authors:  Ari B Molofsky; Frédéric Van Gool; Hong-Erh Liang; Steven J Van Dyken; Jesse C Nussbaum; Jinwoo Lee; Jeffrey A Bluestone; Richard M Locksley
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

View more
  27 in total

Review 1.  Host and Viral Determinants of Respiratory Syncytial Virus-induced Airway Mucus.

Authors:  Matthew T Stier; R Stokes Peebles
Journal:  Ann Am Thorac Soc       Date:  2018-11

Review 2.  Innate lymphoid cells and allergic disease.

Authors:  Matthew T Stier; R Stokes Peebles
Journal:  Ann Allergy Asthma Immunol       Date:  2017-12       Impact factor: 6.347

3.  NFATc1-E2F1-LMCD1-Mediated IL-33 Expression by Thrombin Is Required for Injury-Induced Neointima Formation.

Authors:  Suresh Govatati; Prahalathan Pichavaram; Jagadeesh Janjanam; Baolin Zhang; Nikhlesh K Singh; Arul M Mani; James G Traylor; A Wayne Orr; Gadiparthi N Rao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06       Impact factor: 8.311

4.  Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation.

Authors:  Kelly M Cautivo; Peri R Matatia; Carlos O Lizama; Nicholas M Mroz; Madelene W Dahlgren; Xiaofei Yu; Julia Sbierski-Kind; Marcela T Taruselli; Jeremy F Brooks; Adam Wade-Vallance; Sofia E Caryotakis; Anthony A Chang; Hong-Erh Liang; Julie Zikherman; Richard M Locksley; Ari B Molofsky
Journal:  Immunity       Date:  2022-02-08       Impact factor: 31.745

5.  Corticosteroid insensitivity persists in the absence of STAT1 signaling in severe allergic airway inflammation.

Authors:  Brandon W Lewis; Devine Jackson; Stephanie A Amici; Joshua Walum; Manel Guessas; Sonia Guessas; Elise Coneglio; Akhila V Boda; Mireia Guerau-de-Arellano; Mitchell H Grayson; Rodney D Britt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-11-10       Impact factor: 5.464

Review 6.  JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians.

Authors:  Helena Stabile; Gianluca Scarno; Cinzia Fionda; Angela Gismondi; Angela Santoni; Massimo Gadina; Giuseppe Sciumè
Journal:  Immunol Rev       Date:  2018-11       Impact factor: 12.988

Review 7.  Antiviral Activities of Group I Innate Lymphoid Cells.

Authors:  Ramon A Lujan; Sophia M Vrba; Heather D Hickman
Journal:  J Mol Biol       Date:  2021-09-22       Impact factor: 5.469

8.  Restriction of Viral Replication, Rather than T Cell Immunopathology, Drives Lethality in Murine Norovirus CR6-Infected STAT1-Deficient Mice.

Authors:  Andrew J Sharon; Heather A Filyk; Nicolette M Fonseca; Rachel L Simister; Renata B Filler; Wallace Yuen; Blair K Hardman; Hannah G Robinson; Jung Hee Seo; Joana Rocha-Pereira; Ian Welch; Johan Neyts; Craig B Wilen; Sean A Crowe; Lisa C Osborne
Journal:  J Virol       Date:  2022-02-02       Impact factor: 6.549

Review 9.  Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.

Authors:  Stephanie Ascough; Suzanna Paterson; Christopher Chiu
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

Review 10.  Group 2 Innate Lymphoid Cells in Pulmonary Immunity and Tissue Homeostasis.

Authors:  Barbara C Mindt; Jörg H Fritz; Claudia U Duerr
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.